<DOC>
	<DOCNO>NCT00814502</DOCNO>
	<brief_summary>The purpose research study compare effectiveness Zolpidem CR placebo improve sleep efficiency people dementia admit hospital symptom . You participate study dementia Alzheimer 's type vascular dementia . This study involve placebo ; placebo tablet look exactly like Zolpidem CR , study drug , contain active study drug . We use placebos see study result due study drug due reason . Zolpidem CR also call Ambien CR widely available prescription . Zolpidem CR approve U.S. Food Drug Administration ( FDA ) short-term treatment insomnia ( trouble fall stay asleep ) .</brief_summary>
	<brief_title>Zolpidem CR Hospitalized Patients With Dementia</brief_title>
	<detailed_description>Sleep pattern normally change age . Sleep/wake cycle appear compromise people suffer dementia . Most research involve sleep dementia involve community dwell nursing home resident . Relatively little known sleep pattern patient dementia develop acute behavioral psychiatric symptom necessitate hospitalization . The relationship sleep disturbance patient behavioral/psychiatric symptom also insufficiently study . The current study examine two set data ( sleep/wake cycle clinical symptom ) population elderly subject Dementia Alzheimer 's type ( DAT ) vascular dementia ( VD ) hospitalization period . We compare sleep outcome measure ( primarily sleep efficiency ) clinical outcome measure subject treat Zolpidem CR Placebo . We utilize double-blind , randomize , placebo-controlled design test hypothesis target sleep disturbance hospitalize elderly subject DAT VD lead improvement sleep clinical outcome .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Dementia , Vascular</mesh_term>
	<mesh_term>Chronobiology Disorders</mesh_term>
	<mesh_term>Zolpidem</mesh_term>
	<criteria>Age 6099 year Clinical diagnosis Dementia Alzheimer 's type Vascular Dementia 1 . Subjects agitate able wear activity monitor ; 2 . Subjects actively suicidal homicidal clinical treatment team considers participation study unsuitable ; 3 . Subjects untreated primary sleep disorder 4 . Subjects receive hypnotic medication participation study ; Subjects receive hypnotic medication normal dos prior Partners Human Subjects Research Application Form Filename : Protocol Summary Version Date : June 1 , 2005 5 enrollment may participate study agree stop receiving hypnotic medication ( see ) . 5 . Subjects receive counter sleep aid . 6 . Subjects commit abstain alcohol use study . 7 . Subjects liver disease . 8 . Subjects know anaphylactic reaction angioedema Zolpidem CR .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Alzheimer disease</keyword>
	<keyword>Dementia , vascular</keyword>
	<keyword>Actigraphy</keyword>
	<keyword>Circadian dysregulation</keyword>
	<keyword>Sleep Disorders</keyword>
	<keyword>Circadian rhythm</keyword>
</DOC>